Whole Exome Analysis of Early Onset Alzheimer's Disease

Abstract

The primary focus toward identification of Alzheimer disease (AD) risk genes over the past five years has been testing the common disease common variant (CDCV) hypothesis through the use of genome-wide association studies (GWAS) in late onset Alzheimer disease (LOAD). While common variation clearly plays a role in AD there is a growing realization that the CDCV hypothesis is unlikely to explain all the genetic effect underlying AD. One alternative hypothesis invokes multiple rare variants (RV) in one or more genes, each with stronger individual effects than CDCV genes. We designed this project to test the rare variant hypothesis in AD by examining those cases with the most severe phenotype as determine by early onset (EOAD, cases with AAO less than 60 years). Although there are three known EOAD genes (PS1, PS2 and APP) they account for only approximately 60-70% of familial EOAD and even less of sporadic EOAD. Thus, the majority of the genetics of EOAD remains unknown. Until now, large extended families with AD in multiple generations were necessary to identify variants of significant effect contributing to AD risk, however, with the advent of new genomic technologies such as high-throughput sequencing technology, small family aggregates and isolated cases, particularly those with an extreme phenotype of the disorder (such as early onset) can be used. Thus, we will utilize whole exome high-throughput sequencing to identify high risk AD variants that we will further characterize with respect to AD. We will examine both Caucasian and Caribbean Hispanic AD populations. Our two pronged approach includes structural characterization at the DNA level (Dr. Pericak-Vance), and analysis of Caribbean Hispanics (Dr. Richard Mayeux). Comparing across populations will be extremely useful. Specifically, high priority RVs identified through the whole exome analysis will be further explored with multiple strategies.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 01, 2015
Accession Number
ADA625871

Entities

People

  • Margaret A. Pericak-Vance

Organizations

  • University of Miami

Tags

DTIC Thesaurus Topics

  • African Americans
  • Alzheimer Disease
  • Caucasians
  • Congenital Hereditary And Neonatal Diseases And Abnormalities
  • Dementia
  • Demographic Cohorts
  • Diseases And Disorders
  • Families (Human)
  • Genes
  • Genetic Phenomena
  • Genetic Structures
  • Genetics
  • Genotypes
  • Medical Genetics
  • Neurodegeneration
  • Parkinson'S Disease
  • Phenotypes

Fields of Study

  • Biology

Readers

  • Molecular Genetics
  • Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.

Technology Areas

  • Biotechnology